Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Dimestrol

From Wikipedia, the free encyclopedia
Chemical compound
Not to be confused withDimethylstilbestrol.
Pharmaceutical compound
Dimestrol
Clinical data
Trade namesDepot-Ostromon; Depot-Oestromon; Depot-Cyren; Synthila
Other namesDianisylhexene; 4,4'-Dimethoxy-α,α'-diethylstilbene; Diethylstilbestrol dimethyl ether; Dimethoxydiethylstilbestrol; (E)-4,4'-(1,2-Diethylethylene)dianisole
Drug classNonsteroidal estrogen;Estrogen ether
Identifiers
  • 1-methoxy-4-[(E)-4-(4-methoxyphenyl)hex-3-en-3-yl]benzene
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.004.542Edit this at Wikidata
Chemical and physical data
FormulaC20H24O2
Molar mass296.410 g·mol−1
3D model (JSmol)
  • CCC(=C(CC)C1=CC=C(C=C1)OC)C2=CC=C(C=C2)OC
  • InChI=1S/C20H24O2/c1-5-19(15-7-11-17(21-3)12-8-15)20(6-2)16-9-13-18(22-4)14-10-16/h7-14H,5-6H2,1-4H3/b20-19+
  • Key:VQOAQMIKPYNCMV-FMQUCBEESA-N

Dimestrol (brand namesDepot-Cyren,Depot-Oestromon), also known asdianisylhexene,4,4'-dimethoxy-α,α'-diethylstilbene,diethylstilbestrol dimethyl ether, anddimethoxydiethylstilbestrol, is asyntheticnonsteroidal estrogen of thestilbestrol group which is related todiethylstilbestrol.[1][2] It has been used clinically as a hormonal therapy in cases of delayed female puberty, hypogonadism, menopausal, and postmenopausal symptoms. It is known to induce the development of femalesecondary sexual characteristics in the case of femaledelayed puberty orhypogonadism.[3] The drug has also been used as a growth promoter inlivestock.[4][5]

DES is a known endocrine disrupting chemical. Molecularly, it is known to increase the risk of aneuploidy via interference with microtubule assembly.[6]

Prior to the 1950s, DES was widely prescribed to pregnant women to prevent miscarriage and preterm labor. A study released in the 1950s found that women who were exposed to DES were at increased risk for cervical and vaginal clear cell adenocarcinoma. Shortly after this finding, the FDA discouraged the prescription of DES to pregnant women. Children were also affected by the maternal use of DES during their gestation. Study findings showed that daughters were more likely to develop fertility complications such as premature delivery, neonatal death, miscarriage, ectopic pregnancy, stillbirth, infertility, and preeclampsia. DES exposed sons may also experience genital abnormalities but no conclusive increased risk of infertility.[7]

In the case of suspected or known exposure to DES before, women are encouraged to receive pelvic examinations, PAP tests, biopsies, and breast examinations. Men should receive routine examinations from their physician in the case of suspected or potential exposure.[7]

The medication has a longduration of action of 6 weeks given byintramuscular injection.[8]

Parenteral potencies and durations of nonsteroidal estrogens
EstrogenFormMajor brand name(s)EPD (14 days)Duration
Diethylstilbestrol (DES)Oil solutionMetestrol20 mg1 mg ≈ 2–3 days; 3 mg ≈ 3 days
Diethylstilbestrol dipropionateOil solutionCyren B12.5–15 mg2.5 mg ≈ 5 days
Aqueous suspension?5 mg? mg = 21–28 days
Dimestrol (DES dimethyl ether)Oil solutionDepot-Cyren, Depot-Oestromon, Retalon Retard20–40 mg?
Fosfestrol (DES diphosphate)aAqueous solutionHonvan?<1 day
Dienestrol diacetateAqueous suspensionFarmacyrol-Kristallsuspension50 mg?
Hexestrol dipropionateOil solutionHormoestrol, Retalon Oleosum25 mg?
Hexestrol diphosphateaAqueous solutionCytostesin, Pharmestrin, Retalon Aquosum?Very short
Note: All byintramuscular injection unless otherwise noted.Footnotes:a = Byintravenous injection.Sources: See template.

See also

[edit]

References

[edit]
  1. ^Elks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 396.ISBN 978-1-4757-2085-3.
  2. ^William Andrew Publishing (22 October 2013).Pharmaceutical Manufacturing Encyclopedia (3rd ed.). Elsevier. pp. 1324–.ISBN 978-0-8155-1856-3.
  3. ^Soviet Genetics. Consultants Bureau. 1982.
  4. ^National Research Council (U.S.). Committee on Animal Nutrition (1953).Hormonal Relationships and Applications in the Production of Meats, Milk, and Eggs: A Report of the Committee on Animal Nutrition. National Academies. pp. 5–13.ISBN 9780598358813. NAP:14582.
  5. ^"Diethylstilbestrol".MeSH. NCBI.
  6. ^Sakakibara Y, Saito I, Ichinoseki K, Oda T, Kaneko M, Saitô H, et al. (August 1991)."Effects of diethylstilbestrol and its methyl ethers on aneuploidy induction and microtubule distribution in Chinese hamster V79 cells".Mutation Research.263 (4):269–76.doi:10.1016/0165-7992(91)90012-S.PMID 1861692.
  7. ^ab"Diethylstilbestrol (DES) and Cancer". 2011-10-05.
  8. ^Kahr H (8 March 2013).Konservative Therapie der Frauenkrankheiten: Anzeigen, Grenzen und Methoden Einschliesslich der Rezeptur. Springer-Verlag. pp. 19–20.ISBN 978-3-7091-5694-0.
Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
Stub icon

Thisantineoplastic orimmunomodulatorydrug article is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Dimestrol&oldid=1252448611"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp